1. Introduction {#sec1}
===============

Psychosocial stress is a significant contributor to the development of mental disorders or behavioral abnormalities such as anxiety, depression, schizophrenia, drug abuse, fear memory formation, or posttraumatic stress disorder \[[@B1]\]. We \[[@B2]\] and others \[[@B3]\] previously reported that social defeat stress, as a model of chronic psychological stress, may significantly induce anxiety-like behaviors. It is estimated that up to approximately 30% of the population is likely to experience various degrees of psychosocial stress in their lifetime, inevitably jeopardizing mental health and leading to substantial social or economic burdens \[[@B4]\]. Therefore, understanding the pathogenesis underlying the transition from chronic stress to a neuropsychiatric disorder is of great clinical significance and could help to identify possible intervention targets.

Long noncoding RNAs (lncRNAs) are a type of nonprotein coding RNA with a length ranging from 200 nucleotides to several hundred kilobases and mainly play a role in the response to harmful external stimuli \[[@B5]\]. In particular, lncRNAs are highly expressed in the central nervous system with large copy numbers and broad diversity. Accumulating evidence suggests that lncRNAs are involved in various levels of regulation of gene expression, including transcription or posttranscription regulation and epigenetic modification \[[@B6]\]. Notably, individual lncRNAs may have various functions, and such complex roles can orchestrate a combination of diverse biological processes.

Related to this high diversity in the central nervous system, animal model and human studies have suggested the participation of specific lncRNAs in multiple neuropsychiatric disorders, including anxiety, depression \[[@B7]\], and schizophrenia \[[@B8]\], via regulating neurodevelopment, neurodegeneration, and neuroimmunity. Certain lncRNAs have even emerged as candidate biomarkers for disease diagnosis, therapy, or prognosis \[[@B9]\]. However, the differential expression sites, binding sites, acting modes, and complex network of lncRNAs, which involve mRNAs, microRNAs,*cis* regulatory elements, and competing endogenous RNA networks, make it difficult to elucidate the specific functions of most lncRNAs \[[@B10]\].

Therefore, in the present study, we sought to investigate the roles of lncRNAs in the mechanism by which repeated or continuous chronic psychological stress induces diverse neuropsychiatric disorders using a mouse model of repeated social defeat (RSD) stress, based on a resident and intruder paradigm. Despite the involvement of several brain regions after repeated stress exposure, such as the amygdala or hippocampus, we chose to focus on the prefrontal cortex (PFC), which is considered to be the most sensitive brain region to control fear and stress responses \[[@B11]\]. Even slight acute stress can lead to rapid and prominent injury of prefrontal cognitive ability, while long-term chronic stress may even change the architecture of the PFC dendrites and thus alter its functional connectivity to the rest of the brain \[[@B12]\]. After inducing anxiety-like behavior, a marker of successful model establishment, we examined differentially expressed (DE) lncRNAs and mRNAs in the PFC of the mice using an RNA-sequencing approach. We further confirmed the RNA-sequencing results with four of the identified DE lncRNAs and mRNAs using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Subsequently, we predicted the biological function of the DE lncRNAs target mRNAs with Gene Ontology (GO) and pathway analyses in the RSD mice, and further constructed systematic functional landscapes of the lncRNAs--mRNAs network with specific bioinformatics approaches. These results can provide new insights and potential intervention targets for the early intervention or treatment of social stress-induced neuropsychiatric disorders.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

Male 6--8-week-old C57/BL6 mice (20--25 g) were used as the residents, and 12-month-old CD-1 mice (30--35 g, retired breeders) were used as the intruders for RSD model establishment; all mice were purchased from Charles River Laboratory (Beijing, China). The C57BL/6 mice were housed in cohorts of three and the CD-1 mice were maintained in individual cages under a 12-h light/dark cycle at 22--24°C with sufficient food and water. All mice were acclimated to the surroundings for 7 days before model establishment. All procedures were conducted after ethical approval of the Institutional Animal Care and Use Committee of Nanjing Medical University (Approval no. 1706017).

2.2. RSD Model Establishment {#sec2.2}
----------------------------

The RSD model was established according to a resident-intruder paradigm as described previously \[[@B13]\]. In detail, an intruder male CD-1 mouse was placed into the home cage of three resident C57BL/6 mice. During the exposure, we recorded the behaviors of the mice to ensure that the intruder CD-1 mouse was acting aggressively, such as exhibiting attack behaviors, within 5--10 minutes after contact, while the resident C57/BL6 mice were presenting typical submissive behaviors, including an upright posture, escape attempts, or crouching. If no attack behaviors were observed by the CD-1 mouse or if the resident C57/BL6 mice attacked the intruder, a different CD-1 mouse was introduced. Each bout of exposure lasted 2 hours and was conducted for six consecutive nights; all anxiety-like behaviors of the C57/BL6 mice were monitored throughout the experiment. As a control, mice in a separate cage and room were left undisturbed under the same condition (3 mice per cage) throughout the experimental period.

2.3. Elevated Plus Maze (EPM) Test {#sec2.3}
----------------------------------

The RSD-induced behavioral changes in C57/BL6 mice were evaluated with an EPM test, as a well-proven animal model for anxiety-like behaviors detection based on the aversion that rodents have for open spaces \[[@B14]\]. In brief, the apparatus contained four arms (70 × 5 cm) in the shape of a cross placed at a height of 75 cm above the floor. At the beginning of each test, the mouse was set into the center of the maze facing an open arm, and allowed to explore the maze*ad libitum*. The test was performed in a quiet room with fixed brightness and the movement trajectory was recorded and analyzed using SuperMaze animal behavior analysis software (Xinxin Ltd., Shanghai, China). The total time spent in the open and closed arms was recorded for each mouse with a 5-minute duration. Either an increase in time spent in the closed arm or a decrease in time spent in the open arm is considered to indicate anxiety-like behavior.

2.4. Tissue Collection and RNA Isolation {#sec2.4}
----------------------------------------

Only mice that presented with anxiety-like behavior were subjected to RNA-sequencing and bioinformatics analysis. For PFC tissue collection, eligible C57/BL6 mice were immediately decapitated after the EPM test. The brains were removed and cut coronally at the caudal border of the olfactory tubercle to remove the PFC \[[@B15]\]. Total RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA, USA). RNA purity was assessed on a NanoPhotometer® spectrophotometer (IMPLEN, CA, USA) and the concentration was measured with Qubit® RNA Assay Kit on a Qubit® 2.0 fluorometer (Life Technologies, CA, USA) according to the manufacturer\'s instructions. In addition, RNA integrity was assessed with RNA Nano 6000 Assay Kit (Agilent Technologies, Foster City, CA, USA).

2.5. Library Preparation for lncRNA Sequencing {#sec2.5}
----------------------------------------------

For RNA sample preparations, 3 *μ*g RNA served as the input material for each sample. Sequencing libraries were obtained using NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) according to the manufacturer\'s protocol with index codes supplemented to generate sequences for each sample. In brief, ribosomal RNA was depleted with residues randomly cut into short fragments. First-strand cDNA was produced via a random hexamer primer, and the second strand was synthesized using DNA Polymerase I and RNase H. dNTPs with dTTP were substituted by dUTP in the reaction buffer. The left overhangs were changed into blunt ends with exonuclease and polymerase. Following adenylation of DNA 3′-ends and hairpin loop structure ligation, the library fragments were purified to select desired cDNA fragments of 150--200 bp. Next, 3 *μ*l USER Enzyme (NEB, USA) was mixed with the resultant cDNA and incubated at 37°C for 15 min followed by 95°C for 5 min. Thereafter, PCR was conducted with Phusion High-Fidelity DNA polymerase, Universal PCR primers, and Index (X) Primer. Finally, the products were purified with the AMPure XP system and the library quality was assessed (Agilent Bioanalyzer 2100 system). The generated libraries were sequenced by KeyGEN BioTECH (Nanjing, China) on an Illumina Hiseq 2500 platform, and 100-bp paired-end reads were produced. There are three samples obtained from three mice in each group, with data pooled for statistical analysis.

2.6. Clustering and Sequencing of lncRNA {#sec2.6}
----------------------------------------

Clustering of the index-coded samples was performed with a cBot Cluster Generation System according to the manufacturer\'s protocol. The library preparations were then sequenced with an Illumina Hiseq system and 150-bp paired-end reads were generated. We controlled the error rates of lncRNAs to be lower than 0.02% for each sample. The transcripts with splices for each sample were screened and combined as lncRNAs using Cuffmerge according to the following criteria: FPKM ≥ 0.5 (Cuffquant), exon number ≥ 2, and length \> 200 bp. In addition, with Cuffcompare Software, we excluded overlapping and potential coding transcripts located in the exon regions \[[@B16]\]. All sequencing services were provided by KeyGEN BioTECH (Nanjing, China).

2.7. Identification of DE lncRNAs and mRNAs {#sec2.7}
-------------------------------------------

We determined the DE lncRNAs and mRNAs using the edgeR package \[[@B17]\] along with the Cufflinks algorithm \[[@B18]\] among the transcripts obtained from RNA-sequencing. A \|log~2~ fold change\| ≥ 1.0 and p value ≤ 0.05 were used as the threshold values for identification of DE transcripts. Other than comparing candidate sequences with those of known lncRNAs with Cuffcompare \[[@B19]\], novel lncRNAs were identified according to the following criteria: (1) transcript length ≥ 200 bp and exon number ≥ 2; (2) a putative open reading frame \< 300 bp; (3) overlapping prediction derived from the coding potential calculator, protein family database \[[@B20]\], and coding-noncoding index (CNCI) \[[@B21]\] related to possible lncRNA; and (4) not matched with known lncRNAs.

2.8. qRT-PCR Validation of DE lncRNAs and mRNAs {#sec2.8}
-----------------------------------------------

Four of the DE lncRNAs and mRNAs were randomly chosen for validation of the RNA-sequencing results in RSD versus control mice using qRT-PCR. In brief, total RNA was obtained from liquid nitrogen-frozen PFC tissues. Aliquots of 1 mg RNA were reverse-transcribed and amplified with a real-time PCR machine (Opticon, MA, USA) according to the manufacturer\'s recommendations. Expression levels of each lncRNA and mRNA were quantitatively calculated as a fold change with the 2^−ΔΔCT^ method. The*Gapdh* gene served as an internal control. The primer sequences used in qPCR are shown in [Table 1](#tab1){ref-type="table"}.

2.9. Functional Prediction of the Target mRNAs of DE lncRNAs in RSD Mice {#sec2.9}
------------------------------------------------------------------------

Since the majority of lncRNAs identified to date have not yet been functionally described, information on their function largely depends on the function prediction of their target mRNAs. lncTar software was used to predict the target mRNAs of the DE lncRNAs. All of the candidate target genes were then screened one by one to explore their possible involvement in psychiatric disorders with Medline database (PUBMED). Further, GO (http://geneontology.org/) was used to interpret the possible functions by forming hierarchical categories based on the biological process, cellular component, and molecular function terms of the DE target genes. GO is a useful bioinformatics tool that unifies the genes and gene product characteristics across all species and serves a good predictor of gene function.

In addition, pathway analyses were performed to identify the significant pathways of the DE targets genes through the Reactome (<https://www.reactome.org>), Kyoto Encyclopedia of Genes and Genomes (KEGG; <http://www.genome.jp/kegg/pathway.html>), Protein ANalysis THrough Evolutionary Relationships (PANTHER; <http://www.pantherdb.org>) and BioCyc (<http://biocyc.org>) databases. Enrichment factor, gene number, and p values were used to evaluate the correlation between target genes and their predicted functions or pathways. A threshold of p \< 0.05 was considered to indicate a significant correlation. Other than KEGG, which stores the higher-order functional information for genes, the Reactome, PANTHER, and BioCyc databases were further screened to systematically elucidate the possible pathways involved in the response to RSD.

2.10. Analysis of lncRNA-mRNA Regulatory Networks {#sec2.10}
-------------------------------------------------

The coexpression regulatory network was constructed to determine the correlated expressed genes and establish lncRNA-mRNA coexpression pairs. Pearson\'s correlation coefficient was used with a default filtering threshold set at 0.99 \[[@B22]\]; the corrected p value of the hypothesis test was determined with the Holm calculation, with a default filtering threshold set at 0.05. Correlations among similar types of RNAs were not considered. lncRNA target genes were predicted with lncTar software.

2.11. Statistical Analysis {#sec2.11}
--------------------------

Data are expressed as mean ± standard error (sem). Unpaired t-test with Welch\'s correction was performed for comparison between two groups, and p \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. RSD for Six Days Successfully Induced Anxiety-Like Behaviors in C57/BL6 Mice {#sec3.1}
---------------------------------------------------------------------------------

As there is individual variation among mice in response to chronic psychological stress, we examined anxiety-like behaviors in each mouse with the EPM test after six nights of exposure to social defeat stress. All six tested C57/BL6 mice demonstrated a significant increase in the time spent in the closed arm and a decrease in the time spent in the open arm compared to the controls ([Figure 1](#fig1){ref-type="fig"}), suggesting anxiety-like behaviors and successful establishment of the RSD model.

3.2. Hundreds of DE lncRNAs and mRNAs Were Identified in RSD Mice {#sec3.2}
-----------------------------------------------------------------

RNA-sequencing revealed that 373 lncRNAs were prominently upregulated and 454 lncRNAs were downregulated in the PFC of RSD mice as compared to that of control C57/BL6 mice. In addition, 1142 and 654 mRNAs were significantly upregulated and downregulated, respectively, in the RSD mice. Data of all differential expressed lncRNAs and mRNAs have been uploaded to GEO database and released since March 5, 2019 (Accession number GSE127812). Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"} list the top 20 upregulated and downregulated lncRNAs and mRNAs in RSD mice, and the volcano plot and heat maps for clustering analysis of DE lncRNAs and mRNAs are shown in Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, respectively. All differentially expressed lncRNAs and mRNAs, along with fold changes and p value were shown in Supplementary Tables 1--4.

3.3. qRT-PCR Validated the RNA-Sequencing Results {#sec3.3}
-------------------------------------------------

qRT-PCR showed that NONMMUT033604.2 and NONMMUT068776.2 were upregulated lncRNAs, and NONMMUT064397.2 and NONMMUT032162.2 were downregulated lncRNAs in RSD mice. In addition, ENSMUST00000106332 and ENSMUST00000088086 were upregulated mRNAs, and ENSMUST00000177637 and ENSMUST00000126073 were downregulated mRNAs in RSD mice. These results were consistent with the RNA-sequencing of these four genes ([Figure 4](#fig4){ref-type="fig"}), thereby validating the reliability of the RNA-sequencing protocol.

3.4. Target mRNA Prediction and Functional Regulatory Network of DE lncRNAs {#sec3.4}
---------------------------------------------------------------------------

As lncRNAs may regulate adjacent protein-coding genes, including mRNAs, we further identified the likely target mRNAs of the identified DE lncRNAs using lncTar software, with a total of 126 target mRNAs determined. Unfortunately, no target mRNAs were identified for the top 20 upregulated and 20 downregulated DE lncRNAs ([Table 2](#tab2){ref-type="table"}), which are more likely to play important roles in the pathogenesis in RSD mice. Indeed, a majority of the lncRNAs had no target mRNAs. Thereafter, we screened all possible target mRNAs according to the fold change in the expression level of two upregulated and two downregulated lncRNAs ([Table 4](#tab4){ref-type="table"}). As shown in [Table 4](#tab4){ref-type="table"}, one lncRNA could potentially target three or more mRNAs, associated with three or more regulatory functions. Thus, as expected, this result highlighted the complex regulatory network between lncRNAs and their target genes, as illustrated in [Figure 5](#fig5){ref-type="fig"}. Furthermore, a total of 14 promising target genes of the DE lncRNAs were identified to participate in the pathogenesis of certain psychiatric disorders ([Table 5](#tab5){ref-type="table"}).

3.5. Functional Prediction of Target mRNAs of DE lncRNAs in RSD Mice {#sec3.5}
--------------------------------------------------------------------

As shown in [Figure 6](#fig6){ref-type="fig"}, the top three significantly changed biological processes after RSD were found to be synaptic transmission, regulation of postsynaptic membrane potential, and establishment of synaptic vesicle localization. The top three enriched cellular components were neuron spine, postsynaptic density, and excitatory synapse, and the top three enriched molecular function terms were glutamate receptor binding, kinase activity, and transferase activity, transferring phosphorous-containing groups. These associations strongly indicate a common dysfunction of synapse in the PFC of RSD mice. The top three enriched pathways associated with the candidate target genes were synaptic adhesion-like molecule (SALM) protein interactions at the synapses, trafficking of *α*-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) receptors, as well as glutamate binding, activation of AMPA receptors, and synaptic plasticity. The top 30 enriched pathway terms are shown in [Figure 7](#fig7){ref-type="fig"}.

4. Discussion {#sec4}
=============

Social defeat is a well-validated model to mimic social stress in rodents \[[@B23]\]. In addition, RSD reproduces the pivotal behavioral, physiological, and immunological changes observed in humans that are subjected to chronic psychosocial stress \[[@B24]\]. As expected, six cycles of social defeat stress successfully induced anxiety-like behaviors in mice, as evidenced by a decrease in time spent in the open arm and in increase of time spent in the closed arm in the EPM test. Moreover, we identified hundreds of lncRNAs and mRNAs that are dysregulated in the mouse PFC after six cycles of social defeat stress, providing a first glimpse into the lncRNAs that might participate in the development of anxiety-like behaviors via multiple complex mechanisms via target regulation. The identified DE lncRNAs were scattered widely across all chromosomes other than sex chromosomes, although the majority are not annotated with available databases. In addition, four of the DE lncRNAs and four mRNAs were verified with qRT-PCR to confirm the reliability of the RNA-sequencing technique. Further, many of the candidate target genes of the DE lncRNAs, such as*Arhgef1, Chchd2, Fam107a, Dlg1, Nova2, Dpf1,*and*Shank3*, are involved in neurite growth, neural development, and synaptic plasticity. Furthermore, informatics analyses highlighted the contribution of synapse dysfunction and abnormal synaptic neurotransmission. Collectively, our findings provide potential candidate biomarkers or intervention targets for chronic psychological stress-induced neuropsychiatric disorders.

Accumulating evidence indicates that lncRNAs play important roles in diverse neuropsychiatric disorders. For example, the etiological lncRNA changes associated with major depressive disorder include the cognitive disorders-related lncRNAs*RNON, HAR1, PACER,*and*BACE1-AS*; synaptic plasticity-related lncRNAs*BDNF-AS, DISC2,*and*BC200;* or lncRNAs related to other psychiatric diseases such as*GOMAFU*and*MALAT-1* \[[@B23]\]. Among these, the lncRNA*GOMAFU*, which is related to schizophrenia, was previously shown to be significantly downregulated in mice with anxiety-like behaviors after fear conditioning \[[@B24]\]. The authors also suggested that*GOMAFU*interacts with the polycomb repressive complex1, BMI1, which regulates expression of the schizophrenia-related gene beta crystallin (*Crybbl*), thus playing a regulatory role in fear-induced anxiety-like behaviors.

Of note, most of the lncRNAs expressed in the mammalian brain are regionally enriched in the hippocampus and PFC, two brain regions with prominent roles in the pathogenesis of neuropsychiatric disorders \[[@B25]\]. Although we identified hundreds of DE lncRNAs and mRNAs in the PFC of RSD mice in our study, the majority could not be associated with a target gene. In fact, only nearly 70% of the lncRNAs in the PFC have been characterized in the mouse genome, and the functions of the majority of these lncRNAs are not well defined \[[@B25]\]. Thus, the unidentified lncRNAs warrant further exploration and might also have a relevant function. Overall, only 126 target mRNAs were identified for the DE lncRNAs identified in our study. Accumulating evidence suggests that lncRNAs not only function as enhancers or repressors to regulate gene expression but also act as molecular assemblers to participate in epigenetic modification \[[@B26]\]. Consistent with this idea, we found a complex regulatory network for lncRNAs and their target genes. For example, upregulated NONMMUG093964.1 can downregulate*Sgpl1* and*Unc13b* but can upregulate*Chst2*; simultaneously,*Chst2*was found to be upregulated by another lncRNA, NONMMUG0956668.1.

Notably, when screening the function of the 126 target genes of the DE lncRNAs, 14 promising genes were found to participate in the pathogenesis of certain psychiatric disorders. For example,*Fam107a*(*Drr1*), the target gene of the lncRNA MERGE.19055.3, is recognized as acting as a unique link between stress and actin dynamics in the brain. FAM107A binds to actin, stabilizes actin filaments, facilitates bundling, and promotes actin-dependent neurite outgrowth, collectively regulating long-term potentiation and cognitive performance \[[@B27]\]. Increased expression levels of*Fam107a* were previously observed in the PFC, hypothalamus, hippocampus, and lateral septum in response to various types of acute social stress \[[@B28]\] or chronic stress such as social defeat or maternal deprivation \[[@B29]\]. Moreover, dysregulated*FAM107A* expression has been reported in postmortem PFC samples of suicide victims with schizophrenia and bipolar disorder \[[@B30]\]. In addition,*Shank3*, regulated by both MERGE.36317.1 and NONMMUG028155.2, encodes a widely expressed scaffolding protein (SHANK3) in the excitatory synapses, and its mutation leads to significant impairment of hyperpolarization activated cation channels, neuronal morphology, and synaptic connectivity \[[@B31]\].*Shank3* gene disruption could reproduce autism-like behaviors, including anxiety, social interaction deficits, and repetitive grooming behaviors, in mice \[[@B32]\], while*Shank3* overexpression could induce manic-like behaviors and seizures \[[@B33]\].*SHANK3*polymorphisms have also been reported in individuals with autism \[[@B34]\], schizophrenia, and bipolar disorder \[[@B35]\]. In contrast to the commonly reported expression regions such as the hypothalamus, ventral tegmental area, and hippocampus, this is the first report demonstrating that the expression of*Shank3*is also dysregulated after social defeat stress in the PFC. Other than these two genes, 18 other genes listed in [Table 5](#tab5){ref-type="table"} also appear to play potential roles in the development of behavioral abnormalities after RSD. Although their exact contribution is still far from clearly elucidated, our results highlight these genes as promising candidates for subsequent validation studies.

Moreover, GO enrichment analyses revealed that the significantly enriched biological process and cellular component terms related to the target genes of DE lncRNAs in RSD were mainly concentrated within the realm of synaptic functioning such as synaptic transmission, postsynaptic membrane potential regulation, and postsynaptic density. Further, the significantly enriched molecular function terms were glutamate receptor binding, kinase activity, or transferase activity, which are also involved in regulating synaptic plasticity and transmission. These findings are consistent with previous studies suggesting that synapse dysfunction such as synaptic formation \[[@B36]\], synaptic remodeling \[[@B37]\], and synaptic plasticity \[[@B38]\] plays a pivotal role in the pathogenesis of psychiatric disorders.

The significantly enriched pathways largely agreed with the GO results. The top three significantly enriched pathways of the DE genes were SALM protein interactions at the synapses, trafficking of AMPA receptors, as well as glutamate binding, activation of AMPA receptors, and synaptic plasticity. Indeed, SALMs, as a group of cell adhesion molecules, participate in regulation of neurite outgrowth, branching, synapse formation, and synaptic maturation \[[@B39]\]. In particular, SALM member 5 has been reported to be associated with severe progressive autism and familial schizophrenia, suggesting its clinical significance. In addition, dysfunction of AMPA receptors as well as the glutamatergic signaling pathway is well recognized to participate in the pathophysiology of psychiatric and neurological disorders \[[@B40]\]. Stein et al.\[[@B41]\] also suggested that synaptic connections damage due to microglia overactivation and the subsequent overproduction of proinflammatory mediators or cytotoxins significantly contributed to the development of social defeat stress-induced psychiatric disorders such as anxiety or depression. These data collectively indicate that maintenance of synapse function and normal neurotransmission may be an effective strategy for the intervention of psychiatric disorders. Nevertheless, several other GO or pathway terms could also be promising alternative directions for further research, and our findings only provide a preliminary exploration for detailed investigations in this regard.

Despite this potential, there are several limitations of this study that should be acknowledged. First, although use of an animal model is an advantageous tool to obtain valuable bioinformatics-based evidence, the results cannot be directly extrapolated to humans due to species differences. Second, other than the PFC, other brain regions such as the amygdala or hippocampus also play important roles in psychological stress-induced neuropsychiatric disorders, and deserve comprehensive exploration in the same regard. Finally, our results provide numerous candidate biomarkers or intervention targets; however, these candidates are only predicted using available informatics analyses or literature, and thus further research is required for validation of their specific roles.

5. Conclusion {#sec5}
=============

We provide the first identification of DE lncRNAs and mRNAs in the mouse PFC after RSD stress using RNA-sequencing. Furthermore, bioinformatics analysis identified promising candidate target genes and the target regulatory network was constructed. These findings provide valuable insights into the molecular mechanisms underlying psychiatric disorders and also open up new possibilities for the development of novel therapeutic strategies for effective intervention.
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Table 1 presents the detailed information of all upregulated lncRNAs. Table 2 presents the detailed information of all downregulated lncRNAs. Table 3 presents the detailed information of all upregulated mRNAs. Table 4 presents the detailed information of all downregulated mRNAs.

###### 

Click here for additional data file.

![EPM test results for control or RSD stress C57/BL6 mice. Time spent in the open and closed arms is shown in (a) and (b), respectively. *∗* p \< 0.05; N = 6 per group.](BMRI2019-7505260.001){#fig1}

![Volcano plot of DE lncRNAs (a) and mRNAs (b) in the PFC of RSD mice. Red and green dots indicate significant upregulated and downregulated genes (\|log~2~ fold change\| ≥ 1.0 and p value ≤ 0.05), respectively.](BMRI2019-7505260.002){#fig2}

![Heat maps of the hierarchical clustering analysis of overall DE lncRNAs (a) and mRNAs (b) in the PFC of RSD mice. Red and green lines indicate significantly upregulated and downregulated genes (\|log~2~ fold change\| ≥ 1.0 and p value ≤ 0.05), respectively.](BMRI2019-7505260.003){#fig3}

![qRT-PCR results for four lncRNAs and four mRNAs in the PFC of RSD versus control mice. Each RNA sample was validated in triplicate, and the relative expression level of each gene was normalized to that of*Gapdh*. Data are expressed as mean ± sem; *∗* p \< 0.05; N = 3 per group.](BMRI2019-7505260.004){#fig4}

![Regulatory network of lncRNAs and their target genes. Triangles and dots indicate lncRNA and mRNA symbols, respectively. Up- or downregulation and the associated fold change is indicated by the color gradient.](BMRI2019-7505260.005){#fig5}

![GO enrichment plot for lncRNAs target mRNAs. The top 30 enriched biological processes (a), cellular component (b), and molecular function (c) are presented according to gene number, p value, and enrichment factor. The horizontal axis represents the enrichment factor of the respective GO term, and the vertical axis indicates the enrichment terms, including their gene number and p value.](BMRI2019-7505260.006){#fig6}

![Pathway analysis for target mRNAs of DE lncRNAs in RSD mice. The top 30 enriched pathways are presented according to gene number, p value, and enrichment factor. The horizontal axis represents the enrichment factor of the respective pathway term, and the vertical axis indicates the enrichment terms, including their gene number and p value.](BMRI2019-7505260.007){#fig7}

###### 

Primer sequences of four changed lncRNAs and four mRNAs.

  *lncRNA (5*′*-3*′)   Left Primer              Right Primer
  -------------------- ------------------------ -----------------------
  NONMMUT033604.2      CCAGTTTCCCCAGCTTTTCC     GATGGCCTTTTCTGGTGCAA
  NONMMUT068776.2      GAACGGCTTTCTTGGTTGGT     CAGAAAAGGAAAGACGGGGC
  NONMMUT064397.2      TCCAGACCTCATTGTGCCAT     AAGTCATGGTGTCTGGTGGT
  NONMMUT032162.2      GCAAAACCACGGTCTCTGTT     AAGGGAATGAGCAAAAGGGC
                                                
  *mRNA (5*′*-3*′)     Forward Primer           Reverse Primer
                                                
  ENSMUST00000106332   GGAGGATGAGATGATGCCAGA    GGTGGCTAGTGTGGGGTCT
  ENSMUST00000088086   CTGCCACTATGGCTGCTGTC     GTTGGGCCGGATGTTCCTG
  ENSMUST00000177637   GAGTATGACGATTCTGCTGAGG   CAGACCGAACGTGAAGACGAG
  ENSMUST00000126073   GTTTCGACAGGGACGAAGTGT    TGGCGTCATACCCTCTAGCA

###### 

The detailed information of the top 20 upregulated and 20 downregulated lncRNAs.

  Gene ID            Log~2~ (fold change)   P value       Position                   Track gene        Ensembl
  ------------------ ---------------------- ------------- -------------------------- ----------------- -----------------
  *Upregulated*                                                                                        
                                                                                                       
  MERGE.45931.1      12.91088841            2.97701E-07   9:-:48651572-48787431      MERGE.45931       \-
  MERGE.29971.2      12.5979981             1.27501E-06   3:+:156929006-156954118    MERGE.29971       \-
  MERGE.19004.1      11.83667969            0.000600608   17:+:27655850-27684915     MERGE.19004       \-
  MERGE.14280.14     11.04431774            0.000406504   14:-:124199717-124259715   MERGE.14280       \-
  MERGE.30796.5      10.7196666             8.19282E-06   4:-:44126220-44233789      MERGE.30796       \-
  MERGE.38869.4      10.70506366            3.51044E-05   7:-:4628406-4640163        MERGE.38869       \-
  MERGE.15745.4      10.60865336            1.5956E-06    15:-:85535462-85581468     MERGE.15745       \-
  MERGE.20730.12     10.36177882            0.000183958   18:-:25477632-25753983     MERGE.20730       \-
  MERGE.1341.5       10.1919799             1.58113E-06   1:-:86350564-86358696      MERGE.1341        \-
  MERGE.27539.21     9.992578443            0.000754913   3:-:32954337-33143076      MERGE.27539       \-
  NONMMUT033604.2    9.91062089             0.014780123   19:-:5795745-5802674       MERGE.22023       NONMMUG020671.2
  MERGE.22227.7      9.815364013            0.008371369   19:-:10245269-10304690     MERGE.22227       \-
  MERGE.28508.9      9.492582162            0.000238493   3:-:89234179-89246309      MERGE.28508       \-
  NONMMUT068776.2    9.321278483            4.16816E-06   9:-:43045840-43050998      MERGE.45767       NONMMUG042569.2
  MERGE.25796.12     9.252992082            0.021990423   2:+:134786530-134876399    MERGE.25796       \-
  MERGE.25558.3      9.208027735            5.45061E-05   2:-:126628915-126675352    MERGE.25558       \-
  MERGE.31159.12     8.696361554            1.64867E-06   4:-:75944806-78211739      MERGE.31159       \-
  MERGE.11150.11     8.6314483              0.015990323   13:+:42766495-42853985     MERGE.11150       \-
  MERGE.43418.4      8.578314356            0.022050483   8:-:70778117-70805014      MERGE.43418       \-
  MERGE.6694.4       8.552744132            0.019202417   11:-:65002041-65162747     MERGE.6694        \-
                                                                                                       
  *Down-regulated*                                                                                      
                                                                                                       
  MERGE.45991.1      -9.94906637902031      0.038769757   9:-:52673044-52764976      MERGE.45991       \-
  MERGE.30595.2      -9.78735268889088      1.63371E-05   4:-:36853371-36863946      MERGE.30595       \-
  MERGE.42349.27     -9.47599858076888      0.036893626   8:-:17288423-17358373      MERGE.42349       \-
  MERGE.45094.8      -9.08839769230148      0.012891112   9:-:28996494-29475815      MERGE.45094       \-
  MERGE.35381.3      -9.06100615414186      0.006457129   5:-:125385977-125389800    MERGE.35381       \-
  MERGE.31194.1      -8.94438291137567      0.02225064    4:-:77979876-78060408      MERGE.31194       \-
  NONMMUT064397.2    -8.93847034165544      1.14889E-05   8:+:3455524-3456604        MERGE.42152       NONMMUG039739.2
  MERGE.19402.3      -8.6496160845675       0.018028188   17:+:39843013-39848788     MERGE.19402       \-
  NONMMUT032162.2    -8.30049078658105      0.000779999   18:+:42333299-42341549     MERGE.21168       NONMMUG019797.2
  NONMMUT061626.2    -8.16044749639102      0.001225066   7:-:59667720-59686523      MERGE.40818       NONMMUG038156.2
  NONMMUT006358.2    -8.15305950707237      1.64402E-05   10:+:79767075-79769983     MERGE.4498        NONMMUG004092.2
  MERGE.30727.11     -7.98663627685412      0.000701231   4:+:42670523-42875985      MERGE.30727       \-
  MERGE.5801.1       -7.78183232281183      0.034757085   11:-:20062304-20112909     MERGE.5801        \-
  MERGE.39926.3      -7.75105196885196      0.011104704   7:-:55973519-56019526      MERGE.39926       \-
  NONMMUT114518.1    -7.74074329257374      2.1705E-08    3:-:158067186-158076112    MERGE.29997       NONMMUG028350.2
  NONMMUT065665.2    -7.66376363738363      0.019642797   8:+:55073249-55077138      NONMMUG040621.2   NONMMUG040621.2
  NONMMUT002531.2    -7.4906570738083       6.51052E-06   1:+:130462576-130557075    NONMMUG001711.2   NONMMUG001711.2
  MERGE.22685.10     -7.2275845681765       0.028413612   19:-:40292253-40513842     MERGE.22685       \-
  MERGE.26379.1      -7.15054223770817      0.024103564   2:+:160644759-160657971    MERGE.26379       \-
  MERGE.26349.9      -7.14898961475035      0.025448296   2:+:157424560-157432084    MERGE.26349       \-

###### 

The detailed information of the top 20 upregulated and 20 downregulated mRNAs.

  Gene ID              Log~2~ (fold change)   P value       Position                   Track gene           Symbol
  -------------------- ---------------------- ------------- -------------------------- -------------------- ----------
  *Upregulated*                                                                                             
                                                                                                            
  ENSMUST00000106332   13.64573771            1.10545E-06   7:+:126950966-126970270    MERGE.41644          Sez6l2
  ENSMUST00000088086   13.33934534            1.42923E-07   2:-:166073920-166155285    MERGE.26566          Sulf2
  ENSMUST00000018122   13.25066286            1.84766E-07   6:-:23262823-23839225      MERGE.36317          Cadps2
  ENSMUST00000173888   12.64197878            1.0155E-06    5:-:134239513-134295608    MERGE.35535          Gtf2i
  ENSMUST00000122356   12.23115962            0.000666844   5:+:81309912-81795216      MERGE.34310          Adgrl3
  ENSMUST00000122037   12.0140956             1.16831E-05   5:+:81309912-81795216      MERGE.34310          Adgrl3
  ENSMUST00000046463   11.97911042            1.82118E-07   15:+:79690895-79721478     MERGE.15503          Gtpbp1
  ENSMUST00000060274   11.8574086             1.03636E-06   12:+:111166548-111267144   MERGE.10361          Traf3
  ENSMUST00000197470   11.43826843            5.87443E-05   3:+:107101146-107107737    MERGE.29111          Kcna2
  ENSMUST00000114573   11.43770849            3.40394E-05   9:-:45937875-45954977      MERGE.45887          Sidt2
  ENSMUST00000038794   11.39272235            2.49989E-06   17:-:56186682-56218889     MERGE.19691          Dpp9
  ENSMUST00000105661   11.12015081            0.000217624   4:+:152096719-152115390    MERGE.32825          Plekhg5
  ENSMUST00000155907   10.85023001            3.19153E-07   15:-:94320334-94404258     ENSMUSG00000022449   Adamts20
  ENSMUST00000107165   10.68586351            0.007139619   7:+:96211671-96908554      MERGE.40725          Tenm4
  ENSMUST00000205303   10.60367115            0.012777534   7:+:56050877-56231132      MERGE.39933          Herc2
  ENSMUST00000032220   10.54711543            0.012894258   6:-:124958816-124965448    MERGE.38366          Cops7a
  ENSMUST00000085374   10.42208914            0.020121527   7:+:45163921-45176138      MERGE.39772          Slc17a7
  ENSMUST00000119385   10.35553984            0.000186106   5:+:81309912-81795216      MERGE.34310          Adgrl3
  ENSMUST00000109923   10.27873852            0.000746337   13:-:55473429-55488111     MERGE.11413          Dbn1
  ENSMUST00000114499   10.2448629             9.59799E-06   X:+:73342621-73359080      MERGE.48255          Zfp275
                                                                                                            
  *Downregulated*                                                                                            
                                                                                                            
  ENSMUST00000177637   -9.35288584494421      2.78E-05      9:-:119901616-120068283    MERGE.47489          Cx3cr1
  ENSMUST00000126073   -8.95676408164527      0.021646      10:-:77290727-77418227     MERGE.4433           Adarb1
  ENSMUST00000188674   -8.91289269577746      0.000705      1:-:71585523-71653172      MERGE.1078           Fn1
  ENSMUST00000110688   -8.89118261770537      0.004053      8:+:22974844-23149933      MERGE.42453          Ank1
  ENSMUST00000041838   -8.65979495858615      0.017237      1:-:25067678-25826760      MERGE.356            Adgrb3
  ENSMUST00000108268   -8.61698882689041      1.36E-05      11:-:78962974-78984946     ENSMUSG00000001123   Lgals9
  ENSMUST00000177432   -8.4434885275684       0.041071      18:+:35965067-36014715     MERGE.20997          Psd2
  ENSMUST00000109081   -8.39951574161647      0.000233      11:+:52004221-52040593     MERGE.6361           Cdkl3
  ENSMUST00000172142   -8.35069645803087      0.00902       14:-:31183313-31206826     MERGE.13022          Nisch
  ENSMUST00000121927   -8.3287767124629       0.002357      16:-:76287400-76373827     MERGE.17718          Nrip1
  ENSMUST00000070878   -8.26269044830275      0.003306      19:-:6977741-6980440       MERGE.22112          Fkbp2
  ENSMUST00000110879   -8.09068328129774      0.015696      8:+:12915975-13019309      MERGE.42277          Mcf2l
  ENSMUST00000103026   -8.03358200414137      0.020021      11:+:117115238-117157559   MERGE.8367           Sec14l1
  ENSMUST00000179728   -7.93052673912365      0.000129      17:+:6978907-7011299       MERGE.18419          Rnaset2b
  ENSMUST00000074989   -7.92684730635352      0.000286      9:+:44499136-44510388      MERGE.45814          Bcl9l
  ENSMUST00000008826   -7.91029239938243      5.21E-06      X:+:74270812-74273135      MERGE.48303          Rpl10
  ENSMUST00000120006   -7.85960187622417      0.001675      7:+:24112314-24127952      MERGE.39138          Zfp112
  ENSMUST00000058041   -7.85110659309311      0.005348      9:-:15316917-15333499      MERGE.44892          Cep295
  ENSMUST00000078200   -7.84051645619264      3.5E-05       7:+:141949751-141999005    MERGE.42082          Brsk2
  ENSMUST00000091037   -7.78007365424463      0.016188      2:-:33406108-33428222      MERGE.23908          Zbtb34

###### 

Detailed information of four significantly changed lncRNAs in RSD mice and their target mRNAs.

  LncRNA Gene ID       lncRNA Symbol        mRNA Gene ID         mRNA Symbol   mRNA Gene Description
  -------------------- -------------------- -------------------- ------------- -----------------------------------------------------------------
  ENSMUST00000163836   ENSMUSG00000087679   ENSMUST00000057676   *Ubald2*      UBA-like domain containing 2
                                            ENSMUST00000126941   *Tarsl2*      \-
                                            ENSMUST00000161254   *Nwd1*        NACHT and WD repeat domain containing 1
                                            ENSMUST00000128145   *Dpf1*        D4, zinc and double PHD fingers family 1
                                            ENSMUST00000151304   *Rabep2*      rabaptin, RAB GTPase binding effector protein 2
                                            ENSMUST00000139831   *Rap1gap*     \-
                                            ENSMUST00000127348   *Gatb*        glutamyl-tRNA(Gln) amidotransferase, subunit B
  MERGE.16056.9        MERGE.16056.9        ENSMUST00000106667   *Ampd2*       \-
                                            ENSMUST00000138620   *Pnkd*        paroxysmal nonkinesigenic dyskinesia
                                            ENSMUST00000137766   *Cox6a1*      \-
  MERGE.36317.1        MERGE.36317.1        ENSMUST00000135214   *Shank3*      \-
  NONMMUT051222.2      NONMMUG031746.2      ENSMUST00000187057   *Apbb1*       amyloid beta (A4) precursor protein-binding, family B, member 1

###### 

Fourteen candidate target genes associated with psychiatric disorders and their gene annotations.

  lncRNA Gene ID       lncRNA Symbol        mRNA Gene ID         mRNA Symbol   Possible gene function in psychiatric disorders
  -------------------- -------------------- -------------------- ------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------
  ENSMUST00000133808   ENSMUSG00000087679   ENSMUST00000129928   *Arhgef1*     Expressed in cortical neural progenitor cells to regulate neurite outgrowth
                                                                               
  MERGE.17177.9        MERGE.17177.9        ENSMUST00000094280   *Chchd2*      Response to mitochondrial stress; its mutation is reported in patients with Parkinson\'s disease
                                                                               
  MERGE.19055.3        MERGE.19055.3        ENSMUST00000137133   *Fam107a*     A unique link between stress and actin dynamics, which regulates long-term potentiation and cognition performance
                                                                               
  MERGE.23389.1        MERGE.23389.1        ENSMUST00000064477   *Dlg1*        A known brake on myelination in the central nervous system
                                                                               
  MERGE.26604.5        MERGE.26604.5        ENSMUST00000172835   *Nova2*       Encodes NOVA2, a neuron specific RNA-binding protein, which regulates axon guidance during cortical development
                                                                               
  MERGE.32926.1        MERGE.32926.1        ENSMUST00000128145   *Dpf1*        Essential for post-mitotic neural development and dendritic morphogenesis
                                                                               
  MERGE.36317.1        MERGE.36317.1        ENSMUST00000135214   *Shank3*      Encodes postsynaptic scaffolding protein SHANK3, essential for hyperpolarization activated cation channels, neuronal morphology, and synaptic connectivity
                                                                               
  MERGE.41589.1        ENSMUST00000135916   MERGE.41589.1        *Dlg4*        Encodes postsynaptic density 95 (PSD95), a major synaptic protein that clusters glutamate receptors and is crucial for synaptic plasticity
                                                                               
  NONMMUT035884.2      NONMMUG022075.2      ENSMUST00000129928   *Arhgef1*     Same as aforementioned
                                                                               
  NONMMUT035884.2      NONMMUG022075.2      ENSMUST00000056129   *Npas4*       As immediate-early gene, *Npas4* affects synaptic connection between excitatory and inhibitory neurons, neural circuit plasticity, and memory formation
                                                                               
  NONMMUT045609.2      NONMMUG028155.2      ENSMUST00000135214   *Shank3*      Same as aforementioned
                                                                               
  NONMMUT055012.2      NONMMUG034136.2      ENSMUST00000114317   *Grin1*       Encodes NMDA receptor GluN1 subunit; its mutation is reported in patients with epileptic encephalopathy, intellectual disability, and movement disorders
                                                                               
  NONMMUT058932.2      NONMMUG036638.2      ENSMUST00000126866   *Sez6*        A candidate gene in autism, bipolar disorder, intellectual disability, and childhood onset schizophrenia
                                                                               
  NONMMUT077752.1      NONMMUG048253.1      ENSMUST00000168513   *Pick1*       Encodes cytosolic protein PICK1, which facilitates the removal of GluA2 subunit from the synaptic plasma membrane
                                                                               
  NONMMUT144756.1      NONMMUG091158.1      ENSMUST00000185503   *Dnajc13*     Dnajc13 mutation confers a toxic gain-of-function, impairs endosomal transport, and is an etiological contributor to Parkinson\'s disease
                                                                               
  NONMMUT149941.1      NONMMUG094248.1      ENSMUST00000020308   *Ddit4*       Encodes DDIT4, a negative regulator of myelination during peripheral nerve system development
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